integrin alpha-v/beta-6 antagonist (Quantum Intelligence)

N/A

Report date: 2025/01/26 19:09:47
NME

Base Information

Drug Nameintegrin alpha-v/beta-6 antagonist (Quantum Intelligence)
Drug Alias NameIntegrin Alpha-V/Beta-6 Inhibitor (Quantum Intelligence)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-6 inhibitorsFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptorsIntegrin alpha-V/beta-6
Therapy Area/IndicationsRejection of organ transplantationFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuantum Intelligence Corp
China Registration ClassN/A

Develop Information

Active CompaniesQuantum Intelligence Corp
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A